Immunomedics, Inc. (NASDAQ:IMMU) Insider Trading Activity – Director Bought 1,000,000 shares of Stock

0

Insider Trading Activity For Immunomedics, Inc. (NASDAQ:IMMU)

Avoro Capital Advisors Llc , Director of Immunomedics, Inc. (NASDAQ:IMMU) reportedly Bought 1,000,000 shares of the company’s stock at an average price of 13.23 for a total transaction amount of $13,230,000.00 SEC Form

Insider Trading History For Immunomedics, Inc. (NASDAQ:IMMU)

  • On 9/13/2013 Don Stark, Director, sold 10,000 with an average share price of $6.08 per share and the total transaction amounting to $60,800.00.
  • On 12/9/2014 Don C Stark, Director, sold 5,500 with an average share price of $4.51 per share and the total transaction amounting to $24,805.00.
  • On 12/11/2014 Mary E Paetzold, Director, sold 10,000 with an average share price of $4.71 per share and the total transaction amounting to $47,100.00.
  • On 6/5/2015 Don C Stark, Director, sold 5,732 with an average share price of $4.14 per share and the total transaction amounting to $23,730.48.
  • On 6/9/2015 Mary E Paetzold, Director, sold 4,677 with an average share price of $4.60 per share and the total transaction amounting to $21,514.20.
  • On 6/12/2015 David M Goldenberg, Chairman, sold 359,653 with an average share price of $4.32 per share and the total transaction amounting to $1,553,700.96.
  • On 6/12/2015 Brian A Markison, Director, sold 5,564 with an average share price of $4.22 per share and the total transaction amounting to $23,480.08.
  • Analyst Ratings History For Immunomedics, Inc. (NASDAQ:IMMU)

    • On 9/17/2018 Goldman Sachs Group Initiated Coverage of rating Buy to Buy with a price target of $36.00
    • On 9/18/2018 Guggenheim Initiated Coverage of rating Buy with a price target of $33.00
    • On 11/5/2018 Morgan Stanley Initiated Coverage of rating Overweight to Overweight with a price target of $38.00
    • On 3/27/2019 Berenberg Bank Initiated Coverage of rating Buy to Buy with a price target of $40.00
    • On 8/19/2019 Cantor Fitzgerald Initiated Coverage of rating Overweight with a price target of $28.00
    • On 9/10/2019 Jefferies Financial Group Set Price Target of rating Buy with a price target of $22.00
    • On 9/10/2019 Piper Jaffray Companies Set Price Target of rating Buy with a price target of $20.00

    Recent Trading Activity for Immunomedics, Inc. (NASDAQ:IMMU)
    Shares of Immunomedics, Inc. closed the previous trading session at with shares trading hands.